Management of Metastatic Bone Pain with Repeated Doses of Rhenium 186-HEDP in Patients Under Therapy with Zoledronic Acid: A Safe and Additively Effective Practice - Concepedia

Concepedia

Publication | Closed Access

Management of Metastatic Bone Pain with Repeated Doses of Rhenium 186-HEDP in Patients Under Therapy with Zoledronic Acid: A Safe and Additively Effective Practice

14

Citations

28

References

2009

Year

Athanasios Zafeirakis, Athanasios Zissimopoulos, Nikolaos Baziotis, Georgios S. Limouris

Cancer Biotherapy and Radiopharmaceuticals

Abstract

Retreatments with (186)Re-HEDP under zoledronic acid provide continuing effectiveness in metastatic bone pain and are safe enough, if an acceptable baseline hematologic status exists.

References

	Year	Citations

Page 1